Cognition Therapeutics Inc (CGTX)

Finanzdaten der Cognition Therapeutics Inc-Aktie (CGTX)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	11.11% -0.01	-0.009	-0.002	-0.006	-0.01
Operating Expenses	7.16% 14.10	15.19	14.74	11.82	8.973
Benefits Costs and Expenses	-	-	-	4.72	6.162
Costs And Expenses	7.17% 14.09	15.18	14.74	4.72	6.162
Provision For Loan, Lease, And Other Losses	-	-	-	-	-
Operating Income/Loss	7.16% -14.10	-15.19	-14.74	-11.82	-8.973
Net Interest Income/Expense	11.11% -0.01	-0.009	-0.002	-0.006	-0.01
Interest Income/Expense After Provision For Losses	11.11% -0.01	-0.009	-0.002	-0.006	-0.01
Income/Loss From Continuing Operations Before Tax	11.11% -0.01	-0.009	-0.002	-4.726	-6.172
Income/Loss From Continuing Operations After Tax	12.41% -9.151	-8.141	-6.749	-4.726	-6.172
Net Income/Loss	12.41% -9.151	-8.141	-6.749	-4.726	-6.172
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	10,037% 33.74	0.3328	30.37	29.61	29.09
Diluted Average Shares	10,037% 33.74	0.3328	30.37	29.61	29.09
Basic Earnings Per Share	0.00% -0.27	-0.27	-0.22	-0.16	-0.21
Diluted Earnings Per Share	0.00% -0.27	-0.27	-0.22	-0.16	-0.21
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-